An interventional study of INVSENSOR00039 in Healthy, sponsored by Masimo Corporation. Completed at 1 site in United States. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-10-06.
Sponsored by Masimo Corporation (part of Danaher Corporation) · Interventional and Other
This study is designed to compare the accuracy of a noninvasive measurement of oxygen saturation compared to reference values obtained by a laboratory blood gas analyzer. Arterial blood samples will be collected from healthy adult subjects while undergoing a desaturation procedure wherein the concentration of oxygen inhaled is slowly reduced. The subject will then be returned to breathing room air.
Masimo Corporation is the lead sponsor of 105 studies on the registry; 1 is open to participants now.
Of its 79 completed or terminated interventional studies of FDA-regulated products, 66 (84%) have results posted.
First submitted before Masimo Corporation became part of Danaher Corporation.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria
Exclusion Criteria (* = per physician discretion)
All subjects who are enrolled into the test group and participate in data collection receive the noninvasive INVSENSOR00039 sensor.
Device: INVSENSOR00039
Noninvasive pulse oximeter sensor
Oxygen Saturation (SpO2) Accuracy of Sensor
Performance of the sensors will be determined by comparing the noninvasive oxygen saturation measurement (SpO2) of the pulse oximeter sensors to the arterial oxygen saturation (SaO2) value obtained from a reference blood sample and calculating the Accuracy root square mean (ARMS) value.
Time frame: 1-5 hours
| Milestone | INVSENSOR00039 |
|---|---|
| Started | 38 |
| Completed | 25 |
| Not completed | 13 |
| Withdrew: Did not proceed due to time constraints | 9 |
| Withdrew: Screen failures | 4 |
Performance of the sensors will be determined by comparing the noninvasive oxygen saturation measurement (SpO2) of the pulse oximeter sensors to the arterial oxygen saturation (SaO2) value obtained from a reference blood sample and calculating the Accuracy root square mean (ARMS) value.
| percentage of oxygen saturation | INVSENSOR00039 |
|---|---|
| Oxygen Saturation (SpO2) Accuracy of Sensor | 1.0 |
Collected over 1 to 5 hours. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| INVSENSOR00039 | 0/25 (0%) | 0/25 (0%) | 0/25 (0%) |
| Age, Categorical(Participants) | INVSENSOR00039 |
|---|---|
| <=18 years | 0 |
| Between 18 and 65 years | 25 |
| >=65 years | 0 |
| Sex: Female, Male(Participants) | INVSENSOR00039 |
|---|---|
| Female | 10 |
| Male | 15 |
| Race/Ethnicity, Customized(Participants) | INVSENSOR00039 |
|---|---|
| Asian or Pacific Islander | 4 |
| Black/African American | 6 |
| Caucasian | 10 |
| Hispanic | 5 |
Documents are hosted by the registry — open the source record to download them.
This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.